<DOC>
	<DOCNO>NCT01634256</DOCNO>
	<brief_summary>The investigator perform double-blind parallel study group show mild hepatic injury subject give Fermented turmeric period 12 week . The investigator measure liver function parameter , include ALT ( Alanine Transaminase ) , AST ( Aspartate Transaminase ) , ALP ( Alkaline Phosphatase ) , γ-GT ( Gamma-Glutamyl Transferase ) , serum bilirubin , monitor blood pressure .</brief_summary>
	<brief_title>A Human Trial Evaluate Efficacy Safety Fermented Turmeric Subjects Showing Mild Hepatic Injury</brief_title>
	<detailed_description />
	<mesh_term>Turmeric extract</mesh_term>
	<criteria>Males female 1970 year old Mild hepatic injury indicate ALT ( Alanine Transaminase ) level ≥ 40 Able give inform consent Allergy hypersensitivity ingredient test product History reaction experimental product gastrointestinal disease Crohn 's disease gastrointestinal surgery Carriers viral hepatitis ( type B C ) History underlie Esophageal varix , hepatic encephalopathy , ascites ( past 12 month ) Participation clinical trial within past 2 month Patients acute hepatitis ( type B C ) History underlie cirrhosis liver cancer History underlie biliary disease jaundice gallstone History underlie kidney disease Chronic renal failure nephrotic syndrome Pregnant , plan become pregnant , breastfeed Laboratory test , medical psychological condition deem investigator interfere successful participation study</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2012</verification_date>
</DOC>